208 related articles for article (PubMed ID: 18675414)
1. Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle-stimulating hormone (FSH) in normoandrogenic ovulatory women undergoing gonadotropin releasing-hormone analog/recombinant human FSH therapy for in vitro fertilization and embryo transfer.
Dumesic DA; Lesnick TG; Stassart JP; Ball GD; Wong A; Abbott DH
Fertil Steril; 2009 Jul; 92(1):217-21. PubMed ID: 18675414
[TBL] [Abstract][Full Text] [Related]
2. Increased adiposity enhances intrafollicular estradiol levels in normoandrogenic ovulatory women receiving gonadotropin-releasing hormone analog/recombinant human follicle-stimulating hormone therapy for in vitro fertilization.
Dumesic DA; Lesnick TG; Abbott DH
J Clin Endocrinol Metab; 2007 Apr; 92(4):1438-41. PubMed ID: 17244784
[TBL] [Abstract][Full Text] [Related]
3. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
Ciepiela P; Dulęba AJ; Kario A; Chełstowski K; Branecka-Woźniak D; Kurzawa R
Hum Reprod; 2019 Nov; 34(11):2244-2253. PubMed ID: 31725884
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon).
de Jong D; Macklon NS; Eijkemans MJ; Mannaerts BM; Coelingh Bennink HJ; Fauser BC;
Fertil Steril; 2001 Apr; 75(4):688-93. PubMed ID: 11287020
[TBL] [Abstract][Full Text] [Related]
5. Gonadotrophin stimulation for in vitro fertilization significantly alters the hormone milieu in follicular fluid: a comparative study between natural cycle IVF and conventional IVF.
von Wolff M; Kollmann Z; Flück CE; Stute P; Marti U; Weiss B; Bersinger NA
Hum Reprod; 2014 May; 29(5):1049-57. PubMed ID: 24608520
[TBL] [Abstract][Full Text] [Related]
6. Serum anti-Müllerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation.
Genro VK; Grynberg M; Scheffer JB; Roux I; Frydman R; Fanchin R
Hum Reprod; 2011 Mar; 26(3):671-7. PubMed ID: 21177311
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
Tsakos E; Tolikas A; Daniilidis A; Asimakopoulos B
Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
[TBL] [Abstract][Full Text] [Related]
8. Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization.
Foong SC; Abbott DH; Zschunke MA; Lesnick TG; Phy JL; Dumesic DA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2327-33. PubMed ID: 16551732
[TBL] [Abstract][Full Text] [Related]
9. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
[TBL] [Abstract][Full Text] [Related]
10. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
11. Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization.
Desforges-Bullet V; Gallo C; Lefebvre C; Pigny P; Dewailly D; Catteau-Jonard S
Fertil Steril; 2010 Jun; 94(1):198-204. PubMed ID: 19361798
[TBL] [Abstract][Full Text] [Related]
12. Anti-Müllerian hormone is highly expressed and secreted from cumulus granulosa cells of stimulated preovulatory immature and atretic oocytes.
Kedem-Dickman A; Maman E; Yung Y; Yerushalmi GM; Hemi R; Hanochi M; Dor J; Hourvitz A
Reprod Biomed Online; 2012 May; 24(5):540-6. PubMed ID: 22421733
[TBL] [Abstract][Full Text] [Related]
13. Serum and follicular fluid hormone levels during in vitro fertilization after short- or long-course treatment with a gonadotropin-releasing hormone agonist.
Bo-Abbas YY; Martin KA; Liberman RF; Cramer DW; Barbieri RL
Fertil Steril; 2001 Apr; 75(4):694-9. PubMed ID: 11287021
[TBL] [Abstract][Full Text] [Related]
14. Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-Müllerian hormone and inhibin-B.
Andersen CY; Lossl K
Fertil Steril; 2008 Jun; 89(6):1760-5. PubMed ID: 17628551
[TBL] [Abstract][Full Text] [Related]
15. Reduced intrafollicular androstenedione and estradiol levels in early-treated prenatally androgenized female rhesus monkeys receiving follicle-stimulating hormone therapy for in vitro fertilization.
Dumesic DA; Schramm RD; Bird IM; Peterson E; Paprocki AM; Zhou R; Abbott DH
Biol Reprod; 2003 Oct; 69(4):1213-9. PubMed ID: 12801996
[TBL] [Abstract][Full Text] [Related]
16. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
[TBL] [Abstract][Full Text] [Related]
17. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
18. Diminished intrafollicular estradiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant human follicle-stimulating hormone.
Foong SC; Abbott DH; Lesnick TG; Session DR; Walker DL; Dumesic DA
Fertil Steril; 2005 May; 83(5):1377-83. PubMed ID: 15866572
[TBL] [Abstract][Full Text] [Related]
19. Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: implications for implantation potential.
Balasch J; Fábregues F; Creus M; Peñarrubia J; Vidal E; Carmona F; Puerto B; Vanrell JA
J Assist Reprod Genet; 2000 Jan; 17(1):20-7. PubMed ID: 10754779
[TBL] [Abstract][Full Text] [Related]
20. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
